Beam Therapeutics Inc.
BEAM
$31.58
-$0.17-0.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 31.74M | 114.11M | 9.70M | 8.47M | 7.47M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.74M | 114.11M | 9.70M | 8.47M | 7.47M |
| Cost of Revenue | 11.06M | 99.28M | 109.77M | 101.76M | 15.73M |
| Gross Profit | 20.68M | 14.83M | -100.07M | -93.29M | -8.26M |
| SG&A Expenses | 34.43M | 32.28M | 26.74M | 26.86M | 27.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 138.95M | 131.55M | 136.51M | 128.62M | 126.76M |
| Operating Income | -107.22M | -17.45M | -126.81M | -120.15M | -119.29M |
| Income Before Tax | -94.32M | 244.30M | -112.73M | -102.29M | -108.33M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -94.32M | 244.30M | -112.73M | -102.29M | -108.33M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -94.32M | 244.30M | -112.73M | -102.29M | -108.33M |
| EBIT | -107.22M | -17.45M | -126.81M | -120.15M | -119.29M |
| EBITDA | -101.61M | -11.78M | -121.25M | -114.61M | -113.76M |
| EPS Basic | -0.91 | 2.37 | -1.10 | -1.00 | -1.23 |
| Normalized Basic EPS | -0.57 | 1.51 | -0.72 | -0.65 | -0.75 |
| EPS Diluted | -0.91 | 2.33 | -1.10 | -1.00 | -1.23 |
| Normalized Diluted EPS | -0.57 | 1.48 | -0.72 | -0.65 | -0.75 |
| Average Basic Shares Outstanding | 103.26M | 102.88M | 102.57M | 102.00M | 87.98M |
| Average Diluted Shares Outstanding | 103.26M | 104.93M | 102.57M | 102.00M | 87.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |